Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integrated Biosystems was a pioneering bioprocessing technology company that specialized in the development of systems for the freezing, storage, and transport of bulk biopharmaceutical products. The company's flagship technology, the CryoVessel, provided a controlled-rate freeze-thaw solution that ensured the stability and integrity of high-value proteins and antibodies. In addition to its cryopreservation solutions, the company was an early leader in the shift toward single-use and disposable bioprocessing equipment. Acquired by Stedim in 2001, the company's innovations were later integrated into the Sartorius Stedim Biotech portfolio following a major merger in 2007. Today, the technologies developed by Integrated Biosystems remain foundational to modern bioprocessing workflows for monoclonal antibodies and other recombinant proteins.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Integrated Biosystems.